SCHEMBL8148183

SCHEMBL8148183

O=C(OCc1ccccc1)N1CCN(c2ccc(-c3ccnc(Cl)n3)cn2)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 1/20 0.53
▸ SMN1; SMN2 Q16637 4/20 0.46
▸ RAB9A P51151 2/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ LMNA P02545 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ ME2 P23368 3/20 0.46
▸ ME1 P48163 3/20 0.46
▸ ME3 Q16798 3/20 0.46
▸ GRM5 P41594 1/20 0.46
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ GRIN2B Q13224 3/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ OPRD1 P41143 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30796957 0.85 TRPV1 (0.53) HDAC1SMN1; SMN2RAB9AGRM5MEN1
SCHEMBL6350032 0.80 ME2 (0.70) HDAC1SMN1; SMN2RAB9AKDM4EALDH1A1
SCHEMBL6950816 0.80 RET (0.54) —
SCHEMBL8145178 0.78 HDAC1 (0.46) HDAC1GRIN2BCYP3A4CYP2D6CYP2C9
SCHEMBL6478335 0.78 HDAC1 (0.61) HDAC1SMN1; SMN2RAB9AKDM4EALDH1A1
SCHEMBL13981711 0.78 HDAC1 (0.67) HDAC1SMN1; SMN2RAB9AKDM4EALDH1A1
SCHEMBL6479590 0.77 ALDH1A1 (0.63) HDAC1SMN1; SMN2RAB9AKDM4EALDH1A1
SCHEMBL8146572 0.77 HDAC1 (0.48) HDAC1SMN1; SMN2RAB9AKDM4EALDH1A1
SCHEMBL22581731 0.77 GRM5 (0.54) HDAC1SMN1; SMN2RAB9AALDH1A1GRM5
SCHEMBL6489304 0.77 HDAC1 (0.55) HDAC1SMN1; SMN2RAB9AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6093716-A Substituted 2-pyrimidineamines and processes for their preparation CELLTECH THERAPEUTICS, LIMITED (GB) 2000-07-25 — — US disclosed
EP-0929549-A1 SUBSTITUTED 2-PYRIMIDINEAMINES, THEIR PREPARATION AND THEIR USE AS PROTEINE KINASE INHIBITORS CELLTECH THERAPEUTICS LIMITED (GB) 1999-07-21 — — EP disclosed
WO-1998011095-A1 SUBSTITUTED 2-PYRIMIDINEAMINES, THEIR PREPARATION AND THEIR USE AS PROTEINE KINASE INHIBITORS CELLTECH THERAPEUTICS LIMITED (GB) 1998-03-19 — — WO disclosed
Send feedback